Meng Huee Lee

Title: Innovative Contributions of Inventor Meng Huee Lee

Introduction

Meng Huee Lee is a prominent inventor based in Jiangsu, China. He has made significant strides in the field of pharmaceutical innovation through his research and development efforts. Known for his dedication to advancing medical science, his inventions are crucial in targeting specific endonucleases related to various diseases.

Latest Patents

Meng Huee Lee holds a notable patent titled "Membrane-type metalloprotease inhibitory protein and pharmaceutical composition containing same, and respective uses thereof." This patent discloses a membrane-type metalloprotease inhibitory protein, referred to as T1, which has applications in preparing drugs aimed at inhibiting MT1-MMP or TACE endonuclease. Additionally, the patent outlines the development of an antitumor pharmaceutical composition that includes BHK-21 cells and an artificial basal membrane expressing the T1 protein. This innovation holds promise for improved therapeutic strategies in oncology.

Career Highlights

Currently, Meng Huee Lee is associated with Xi'an Jiaotong University, where he engages in groundbreaking research that bridges the gap between laboratory discoveries and clinical applications. His work at this esteemed institution underscores his commitment to fostering advancements in the pharmaceutical field.

Collaborations

In his professional journey, Meng Huee Lee has collaborated with esteemed colleagues such as Bingjie Jiang and Jian Liu. These partnerships enhance the research process, leveraging diverse expertise to drive innovation and exploration in complex medicinal challenges.

Conclusion

In summary, Meng Huee Lee is an influential inventor whose patent on a metalloprotease inhibitory protein exemplifies his contributions to pharmaceutical research. His collaborations and position at Xi'an Jiaotong University highlight his importance in the ongoing pursuit of innovative medical solutions.